We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+12.81%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$283M
AUM Growth
+$162M
Cap. Flow
+$72.6M
Cap. Flow %
25.66%
Top 10 Hldgs %
42.53%
Holding
215
New
70
Increased
65
Reduced
14
Closed
66

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$2.38M
2
WMT icon
Walmart Inc
WMT
+$2.38M
3
JPM icon
JPMorgan Chase
JPM
+$2.13M
4
FATE icon
Fate Therapeutics
FATE
+$1.92M
5
FTNT icon
Fortinet
FTNT
+$1.5M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$2.05M
2
PFE icon
Pfizer
PFE
+$1.44M
3
CVS icon
CVS Health
CVS
+$1.41M
4
MET icon
MetLife
MET
+$1.4M
5
DE icon
Deere & Co
DE
+$1.24M

Sector Composition

Rank Sector Weight
1 Financials 18.71%
2 Technology 15.05%
3 Industrials 8.12%
4 Healthcare 7.38%
5 Energy 5.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBOE icon
51
Cboe Global Markets
CBOE
$29.5B
$1.34M 0.47%
+10,672
New +$1.32M
ANET icon
52
Arista Networks
ANET
$250B
$1.34M 0.47%
44,040
+15,280
+53% +$470K
VRTX icon
53
Vertex Pharmaceuticals
VRTX
$134B
$1.33M 0.47%
+4,615
New +$1.41M
AME icon
54
Ametek
AME
$58.8B
$1.33M 0.47%
+9,518
New +$1.26M
PH icon
55
Parker-Hannifin
PH
$134B
$1.29M 0.46%
+4,441
New +$1.27M
LRCX icon
56
Lam Research
LRCX
$390B
$1.29M 0.46%
30,730
+10,610
+53% +$444K
ENPH icon
57
Enphase Energy
ENPH
$5.59B
$1.27M 0.45%
4,808
+2,213
+85% +$644K
MNDY icon
58
monday.com
MNDY
$3.7B
$1.26M 0.45%
+10,347
New +$1.08M
MRK icon
59
Merck
MRK
$322B
$1.25M 0.44%
11,243
-3,777
-25% -$386K
AYX
60
DELISTED
Alteryx Inc
AYX
$1.22M 0.43%
+24,113
New +$1.15M
GWW icon
61
W.W. Grainger
GWW
$61.3B
$1.21M 0.43%
2,183
+982
+82% +$554K
ROP icon
62
Roper Technologies
ROP
$39.5B
$1.2M 0.43%
+2,783
New +$1.15M
NBIX icon
63
Neurocrine Biosciences
NBIX
$16.5B
$1.15M 0.41%
9,623
+4,195
+77% +$491K
ITCI
64
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.13M 0.4%
+21,432
New +$1.07M
HCP
65
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$1.12M 0.4%
41,138
+23,819
+138% +$674K
CFLT
66
DELISTED
Confluent
CFLT
$1.12M 0.4%
+50,435
New +$1.17M
LNTH icon
67
Lantheus
LNTH
$6.57B
$1.12M 0.4%
21,979
+14,577
+197% +$899K
PPG icon
68
PPG Industries
PPG
$25.8B
$1.12M 0.4%
8,891
+3,904
+78% +$478K
IBP icon
69
Installed Building Products
IBP
$6.63B
$1.11M 0.39%
+13,022
New +$1.1M
HIBB
70
DELISTED
Hibbett, Inc. Common Stock
HIBB
$1.11M 0.39%
+16,306
New +$1.02M
RES icon
71
RPC Inc
RES
$1.4B
$1.11M 0.39%
+124,913
New +$1.13M
XM
72
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
$1.11M 0.39%
+106,781
New +$1.12M
PCOR icon
73
Procore
PCOR
$8.93B
$1.11M 0.39%
+23,428
New +$1.2M
EVBG
74
DELISTED
Everbridge, Inc. Common Stock
EVBG
$1.11M 0.39%
+37,367
New +$1.15M
NTNX icon
75
Nutanix
NTNX
$17.4B
$1.1M 0.39%
+42,263
New +$1.15M
1 2
3
4 5

Similar funds

CAWM
Capital A Wealth Management New Castle, Pennsylvania $8.94M AUM
AI
Allostery Investments Stamford, Connecticut $7.85M AUM
PC
Prysm Capital Princeton, New Jersey $10.6M AUM 2.38% 1-Year Est. Return
CP
Castalian Partners Excelsior, Minnesota $7.36M AUM
AVM
Altos Ventures Management Burlingame, California $11.7M AUM 182.72% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
NP
Newlight Partners New York $3.9M AUM 96.05% 1-Year Est. Return
BPWM
Black Point Wealth Management Naples, Florida $3.5M AUM 16.42% 1-Year Est. Return

Alpha DNA Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, Alpha DNA Investment Management held 215 positions worth $283M, up 135% from $120M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Alpha DNA Investment Management deployed $72.6M of net new capital in Q4 2022, opening 70 new positions and adding to 65 existing holdings. Its largest new stake was Fate Therapeutics: 102,094 shares worth $1.03M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was ExxonMobil, an estimated $2.05M trimmed.

  • Alpha DNA Investment Management's largest Q4 2022 buy was Fate Therapeutics: 102,094 shares worth $1.03M.
  • Alpha DNA Investment Management added most to McDonald's in Q4 2022, an estimated $2.38M increase.
  • Alpha DNA Investment Management's biggest Q4 2022 reduction was ExxonMobil, cutting an estimated $2.05M.
  • Alpha DNA Investment Management fully exited CVS Health in Q4 2022, selling an estimated $1.41M.
  • Alpha DNA Investment Management's ten largest holdings make up 43% of its $283M portfolio in Q4 2022.
  • Alpha DNA Investment Management opened 70 new positions and closed 66 in Q4 2022.
  • Alpha DNA Investment Management's portfolio value rose 135% quarter-over-quarter to $283M.

Based on Alpha DNA Investment Management's 13F filing for Q4 2022, filed 27 Jan 2023.